In response to the Federal Competition Commission’s blocking of Nestle SA’s $11.85 billion buyout of Pfizer Inc.’s infant nutrition business due to competition concerns, Nestle has reportedly agreed to divest Pfizer’s baby formula operations. The CFC originally blocked the deal last November after it found Nestle, which is based in Switzerland, would have too much of a dominant position in the market in Mexico after the acquisition. The competition authority has announced its approval of the concessions. Nestle outbid Groupe Danone SA to buy the Pfizer conglomerate last year.
Featured News
FTC Moves to Block Henkel Deal for Liquid Nails Owner
Dec 14, 2025 by
CPI
US Appeals Court Hears Challenge to False Claims Act Whistleblower Powers
Dec 14, 2025 by
CPI
Federal Judge Again Throws Out Antitrust Lawsuit Against Visa
Dec 14, 2025 by
CPI
California Judge Expands Antitrust Lawsuit Against Live Nation and Ticketmaster
Dec 14, 2025 by
CPI
NY Laws Requires Disclosure of AI Actors in Ads, Limit Use of Person’s Image After Death
Dec 12, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Acqui-hiring
Dec 11, 2025 by
CPI
Anticompetitive Effects of Acquihires: Labor and Product Markets
Dec 11, 2025 by
Heski Bar-Isaac, Justin Johnson & Volker Nocke
Acquihires In the Technology Sector: Antitrust Scrutiny Through the Lens of Economics
Dec 11, 2025 by
Juliette Caminade, Rebecca Kirk Fair, Zsolt Udvari & Jeanne Vellard Smith
M&A in the AI Era: Considerations for Acquihiring
Dec 11, 2025 by
Ingrid Vandenborre, Kenneth Schwartz, Christopher Barlow, Page Griffin, Michael Cardella, Stuart Levi, Taylor Votek, Benjamin Salzer, Lisa G. Liu & Liz Kraus
Lock Them Up, or Take No Prisoners? Merger Policy and Acquiring AI Talent: Human Rights and Other Inconvenient Facts
Dec 11, 2025 by
Simon R. Pritchard